Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending October 2013. The report details a specific share repurchase transaction executed on October 17, 2013, under authority granted by shareholders at the Annual General Meeting on May 1, 2013.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on capital structure changes related to share buybacks.
- Shares Purchased: 1,426,000 Ordinary Shares of 25 pence each.
- Price Range: Highest price paid was 1,586.50 pence per share; lowest price paid was 1,564 pence per share.
- Treasury Holdings (Settled): 498,810,912 shares, representing 9.29% of total issued share capital.
- Treasury Holdings (Including Unsettled): 503,095,912 shares, representing 10.33% of current total voting rights.
- Shares in Issue (Excluding Treasury): 4,868,199,089 shares.
Material Changes
The primary material change is the reduction of outstanding shares and the increase in treasury stock following the October 17 transaction. The filing does not provide comparative financial data against prior periods to assess year-over-year changes in operational metrics.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. It includes a standard disclaimer stating the announcement does not constitute an offer or solicitation to purchase securities and confirms conformity with the Financial Conduct Authority's Disclosure and Transparency Rules.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (498,810,912 settled) against the company's latest capitalization table.
- Confirm the percentage of total voting rights held in Treasury (10.33% including unsettled shares) for disclosure threshold calculations.
- Check the remaining authorized share buyback limit following this transaction.
- Review the settlement status of the 4,285,000 shares purchased but not yet settled.